MDxHealth is trading 5.66% higher at $0.64 after no clear company-specific catalyst was identified for September 24, 2026.
- The company’s official 2026 archive lists no releases dated September 22–24; its latest announcement was August 13 second-quarter results.
- Broader markets are weaker, so the gain does not clearly track overall sentiment.
- The move may reflect low-liquidity pre-market activity, but confirmation is unavailable.